Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 475,598 | 18,662 | 34,288 | 31,176 | 15,353 |
| Gross Profit | 475,598 | 18,662 | 34,288 | 31,176 | 15,353 |
| Operating Expenses | 892,317 | 139,243 | 208,206 | 202,886 | 284,466 |
| Operating Income | -416,719 | -120,581 | -173,918 | -171,710 | -269,113 |
| Interest Expense | 15,145 | 13,612 | 13,612 | 14,072 | 12,965 |
| Other Income | 13,605 | 1,499 | 2,782 | 2,013 | 2,112 |
| Pre-tax Income | -418,259 | -132,694 | -184,748 | -183,769 | -279,966 |
| Net Income Continuous | -418,259 | -132,694 | -184,748 | -183,769 | -279,966 |
| Net Income | $-418,259 | $-132,694 | $-184,748 | $-183,769 | $-279,966 |
| EPS Basic Total Ops | -7.27 | -5.51 | -9.99 | -12.56 | -20.60 |
| EPS Basic Continuous Ops | -7.27 | -5.51 | -9.99 | -12.56 | -20.68 |
| EPS Diluted Total Ops | -7.27 | -5.51 | -9.99 | -12.56 | -20.60 |
| EPS Diluted Continuous Ops | -7.27 | -5.51 | -9.99 | -12.56 | -20.68 |
| EPS Diluted Before Non-Recurring Items | -7.27 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-411,834 | $-114,905 | $-164,335 | $-160,469 | $-259,303 |